Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information

Human immunoglobulin

EU orphan designation number: EU/3/03/170
Active ingredient: Human immunoglobulin
Indication: Treatment of polymyositis
Sponsor: Orfagen
CRDPF Langlade, 3 avenue Hubert Curien, BP 13562, F-31035 Toulouse CEDEX 1, France

   Public summary of scientific opinion    


European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
28/10/2003 Centralised Orphan - Designation EMEA/OD/039/03 (2003)4016 of 24/10/2003
30/05/2011 Other procedure EMEA/OD/039/03
30/09/2013 Centralised Orphan - Removal of orphan designation from Community Register